| Literature DB >> 19649172 |
Eufemia Jacob1, Marilyn Hockenberry, Brigitta U Mueller.
Abstract
The use of hydromorphone is increasing but little is known about its effects during painful episodes in adolescents with sickle cell disease. This pilot study examined the intensity, location, and quality of pain and evaluated the amount of relief and side effects from PCA hydromorphone during acute painful episodes in five adolescents with sickle cell disease. Data suggest that hydromorphone may provide a better alternative than morphine, the most commonly prescribed opioid in patients with sickle cell disease. Hydromorphone may provide improved pain control and recovery from acute painful episodes in patients with sickle cell disease.Entities:
Year: 2008 PMID: 19649172 PMCID: PMC2718784
Source DB: PubMed Journal: J Pain Manag ISSN: 1939-5914